Marion Istvan
Overview
Explore the profile of Marion Istvan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
37
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Duval M, Istvan M, Rousselet M, Laforgue E, Grall-Bronnec M, Mauriat C, et al.
Eur Addict Res
. 2024 Dec;
1-12.
PMID: 39622223
Introduction: Cannabidiol (CBD) is one of the two primary phytocannabinoids found in cannabis. Its diverse pharmacological properties suggest potential benefits for a wide range of medical conditions. The primary objective...
2.
Chaaban S, Istvan M, Schreck B, Laigo P, Rousselet M, Grall-Bronnec M, et al.
BMC Public Health
. 2024 Apr;
24(1):992.
PMID: 38594675
Background: Chronic use of cannabis is associated with an increased risk of psychosocial, mental and physical health impairments. Sociohealth institutions reach a very limited proportion of cannabis users in need...
3.
Istvan M, Duval M, Hodel K, Aquizerate A, Chaslerie A, Artarit P, et al.
Eur Arch Psychiatry Clin Neurosci
. 2024 Mar;
PMID: 38499795
The COVID-19 pandemic has had a substantial impact on mental health. An increase in the use of anxiolytic, hypnotic, and antidepressant drugs has been highlighted in France, but with no...
4.
Laforgue E, Istvan M, Chaslerie A, Artarit P, Vallot G, Jolliet P, et al.
Epidemiol Psychiatr Sci
. 2023 Sep;
32:e59.
PMID: 37723967
Aims: Despite recommendations to initiate clozapine after two unsuccessful trials of antipsychotics, clozapine is underprescribed and initiated too late. The aim of this study was to describe different antipsychotic treatment...
5.
Guerlais M, Aquizerate A, Lionnet A, Daveluy A, Duval M, Gerardin M, et al.
Front Public Health
. 2023 May;
11:1167746.
PMID: 37206871
Introduction: Nitrous oxide has become over the last few years a public health problem in many countries. France has a dedicated health monitoring system dedicated to the surveillance of the...
6.
Istvan M, Bresdin V, Mainguy M, Laigo P, Grall-Bronnec M, Eudeline V, et al.
Harm Reduct J
. 2023 Mar;
20(1):43.
PMID: 36991395
Background: Illicit substance use has constantly evolved over the years, particularly in the party scene. Monitoring these changes is essential to adapt harm reduction strategies. The OCTOPUS survey was implemented...
7.
Schreck B, Istvan M, Guerlais M, Laforgue E, Gerardin M, Grall-Bronnec M, et al.
Curr Drug Metab
. 2023 Feb;
24(2):80-91.
PMID: 36852802
Background: Slamming has been increasing internationally for ten years, mostly among men who have sex with men. Slamming consists of injecting psychostimulants (including new psychoactive substances-NPS) intravenously to increase sexual...
8.
Aquizerate A, Laforgue E, Istvan M, Rousselet M, Gerardin M, Jouanjus E, et al.
Eur J Public Health
. 2023 Feb;
33(2):169-175.
PMID: 36749030
Background: Since the appearance of zolpidem on the market, the occurrence of serious cases of abuse, misuse and dependence have come to the attention of authorities. In view of the...
9.
Laforgue E, Rousselet M, Claudon A, Aquizerate A, Jolliet P, Istvan M, et al.
Int J Environ Res Public Health
. 2022 Jul;
19(15).
PMID: 35897285
Background: The French national drug regulatory authority stated, in 2017, that a secured prescription pad must be used for zolpidem prescriptions. This study aimed to evaluate the evolution of the...
10.
Laforgue E, Istvan M, Schreck B, Mainguy M, Jolliet P, Grall-Bronnec M, et al.
J Clin Med
. 2022 Apr;
11(8).
PMID: 35456269
Background: To “limit the risk of abuse and misuse” and “encourage correct usage”, the French drug regulatory authority stated that—from April 2017—zolpidem prescription must be performed on a secured prescription...